查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
皮膚科治療市場份額、規模、趨勢、行業分析報告：按治療領域、按藥物類別、按給藥途徑（局部、口服、腸胃外）、按分銷渠道、按地區、細分市場預測，2023-2032年
市場調查報告書
商品編碼
1287729

皮膚科治療市場份額、規模、趨勢、行業分析報告：按治療領域、按藥物類別、按給藥途徑（局部、口服、腸胃外）、按分銷渠道、按地區、細分市場預測，2023-2032年

Dermatology Drugs Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Area; By Drug Class; By Route of Administration (Topical, Oral, Parenteral); By Distribution Channel; By Region; Segment Forecast, 2023 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的一項新研究，到 2032 年，全球皮膚科市場預計將達到 504.7 億美元。 該報告深入探討了當前市場動態，並對未來市場增長進行了分析。

由於全球皮膚病患病率不斷上升，負擔日益加重，皮膚病治療市場的需求正在激增。 對疾病進展和病因學的認識不斷增強，增加了對有效治療的需求。 老年人口的增加對市場的增長做出了重大貢獻。

由於與衰老相關的各種生理變化，老年人更容易患皮膚相關疾病。 例如，結締組織的變化、皮膚強度和彈性的喪失、皮脂腺分泌減少是老年人的常見現象，導致皮膚科藥物的需求增加。

皮膚科是一門多元化的專業，涵蓋皮膚、粘膜、頭髮和指甲的紊亂和疾病。 此類疾病包括痤瘡、多炎性皮炎、皮膚癌、自身免疫性疾病、職業性皮炎和接觸性皮炎。 痤瘡、酒渣鼻、牛皮癬、特應性皮炎等是非常細分的治療領域。

由於其功效和針對性方法，生物製劑已成為皮膚病的流行治療選擇，許多藥物已獲得監管部門的批准，還有更多藥物正在開發中。 由於局部治療方便、副作用較少且有針對性，患者也更喜歡局部治療而不是全身藥物，從而導致對局部皮膚病藥物的需求增加。 新興市場需求的增長、聯合療法的日益採用以及對個性化醫療的關注也推動了該行業的增長。

例如，2022年3月，強生旗下楊森製藥公司發布了藥物安全性報告，並啟動了一項名為VISIBLE的前瞻性臨床試驗來評估療效。

皮膚科藥物市場報告亮點

  • 由於全球銀屑病患病率不斷上升以及製造商推出治療方法，銀屑病細分市場佔據了最大的市場份額。
  • 皮質類固醇廣泛用於治療各種皮膚病表現，包括牛皮癬、皮炎和痤瘡。
  • 父母用藥佔據了最大的市場份額，因為有多種可用於治療皮膚病的生物製劑，而生物製劑通常通過腸胃外給藥途徑服用。因為它會完成。
  • 醫院藥房行業在市場中佔據主導地位，預計在預測期內將繼續保持這種主導地位。 如今，人們對皮膚病的認識更加深刻，這導致更多的患者去醫院就診，處方藥的銷量也隨之增加。
  • 北美佔據最大的市場份額，預計在預測期內將保持其主導地位。 對皮膚病的認識提高、治療方法的成熟以及進入該市場的主要參與者正在推動該地區的增長。
  • 主要全球市場參與者：Lupin、諾華公司、羅氏有限公司、輝瑞公司、賽諾菲公司、安進公司、禮來公司、阿斯利康公司、艾伯維公司、強生私人有限公司、LEO Pharma A/S、默克公司、Bausch Health Companies Inc.、百時美施貴寶公司

內容

第一章簡介

第 2 章執行摘要

第三章研究方法

第 4 章全球皮膚科市場洞察

  • 皮膚科治療 - 行業概況
  • 皮膚科藥物市場動態
    • 驅動因素和機遇
      • 老年人口不斷增加
      • 臨床研究的增加
    • 制約因素和問題
      • 成本高
  • 杵分析
  • 皮膚科藥品行業的趨勢
  • 價值鏈分析
  • COVID-19 感染的影響分析

第 5 章全球皮膚科藥物市場（按治療領域）

  • 主要發現
  • 簡介
  • 痤瘡
  • 特應性皮炎
  • 牛皮癬
  • 酒渣鼻樣皮炎
  • 其他

第 6 章全球皮膚科藥物市場（按藥物類別）

  • 主要發現
  • 簡介
  • 抗感染藥
  • 皮質類固醇
  • 抗痘
  • 鈣調神經磷酸□抑製劑
  • 類維生素A
  • 其他

第 7 章全球皮膚科市場（按給藥途徑）

  • 主要發現
  • 簡介
  • 本地
  • 口頭
  • 注射用

第 8 章全球皮膚科藥物市場（按分銷渠道）

  • 主要發現
  • 簡介
  • 醫院藥房
  • 零售藥店
  • 網上藥店

第 9 章：全球皮膚科藥物市場（按地區）

  • 主要發現
  • 簡介
    • 2019-2032 年按地區劃分的皮膚科藥物市場評估
  • 皮膚科藥物市場 - 北美
    • 北美：皮膚科治療市場，按治療領域，2019-2032 年
    • 北美：皮膚科治療市場，按分銷渠道劃分，2019-2032 年
    • 北美：皮膚科治療市場，按藥物類別，2019-2032 年
    • 北美：皮膚科治療市場，按給藥途徑劃分，2019-2032 年
    • 皮膚科藥物市場 - 美國
    • 皮膚科治療市場 - 加拿大
  • 皮膚科藥物市場 - 歐洲
    • 歐洲：2019-2032 年皮膚科藥物市場（按治療領域）
    • 歐洲：按分銷渠道劃分的皮膚科市場，2019-2032 年
    • 歐洲：皮膚科藥物市場，按藥物類別，2019-2032 年
    • 歐洲：按給藥途徑劃分的皮膚科市場，2019-2032 年
    • 皮膚科治療市場 - 英國
    • 皮膚科藥物市場 - 法國
    • 皮膚科藥物市場 - 德國
    • 皮膚科藥物市場 - 意大利
    • 皮膚科藥物市場 - 西班牙
    • 皮膚科藥物市場 - 荷蘭
    • 皮膚科藥物市場 - 俄羅斯
  • 皮膚科藥物市場 - 亞太地區
    • 亞太地區：2019-2032 年皮膚科治療市場（按治療領域）
    • 亞太地區：皮膚科治療市場，按分銷渠道劃分，2019-2032 年
    • 亞太地區：皮膚科治療藥物市場，按藥物類別，2019-2032 年
    • 亞太地區：皮膚科治療市場，按給藥途徑劃分，2019-2032 年
    • 皮膚科藥物市場 - 中國
    • 皮膚科藥物市場 - 印度
    • 皮膚科藥物市場 - 日本
    • 皮膚科藥物市場 - 馬來西亞
    • 皮膚科藥物市場 - 印度尼西亞
    • 皮膚科藥物市場 - 韓國
  • 皮膚科藥物市場 - 中東和非洲
    • 中東和非洲：2019-2032 年按治療領域劃分的皮膚科藥物市場
    • 中東和非洲：2019-2032 年按分銷渠道劃分的皮膚科藥物市場
    • 中東和非洲：皮膚科治療藥物市場（按藥物類別），2019-2032 年
    • 中東和非洲：2019-2032 年按給藥途徑劃分的皮膚科藥物市場
    • 皮膚科藥物市場 - 沙特阿拉伯
    • 皮膚科治療市場 - 南非
    • 皮膚科藥物市場 - 以色列
    • 皮膚科治療市場 - 阿拉伯聯合酋長國
  • 皮膚科藥物市場 - 拉丁美洲
    • 拉丁美洲：皮膚科治療市場，按治療領域，2019-2032 年
    • 拉丁美洲：皮膚科治療市場，按分銷渠道劃分，2019-2032 年
    • 拉丁美洲：皮膚科治療市場，按藥物類別，2019-2032 年
    • 拉丁美洲：按給藥途徑劃分的皮膚科治療市場，2019-2032 年
    • 皮膚科藥物市場 - 墨西哥
    • 皮膚科藥物市場 - 巴西
    • 皮膚科藥物市場 - 阿根廷

第 10 章競爭格局

  • 擴張和收購分析
    • 擴展名
    • 收購
  • 合作/協作/協議/出版

第 11 章公司簡介

  • Lupin
  • Novartis AG
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc
  • Sanofi
  • Amgen Inc
  • Lilly
  • AstraZeneca
  • AbbVie Inc.
  • Johnson & Johnson Private Limited
  • LEO Pharma A/S
  • Merck & Co. Inc
  • Bausch Health Companies Inc
  • Bristol-Myers Squibb Company
Product Code: PM1106

The global dermatology drugs market size is expected to reach USD 50.47 billion by 2032, according to a new study by Polaris Market Research. The report "Dermatology Drugs Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Area; By Drug Class; By Route of Administration (Topical, Oral, Parenteral); By Distribution Channel; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The dermatology drugs market is experiencing a surge in demand due to a growing burden of dermatology diseases globally, with increasing prevalence rates. Increased awareness of disease progression and etiology has increased, leading to a higher demand for effective treatments. The rise in the elderly population has contributed significantly to the market's growth.

Older individuals are more susceptible to skin-related disorders due to various physiological changes associated with aging. For instance, changes in the connective tissue, reduction in skin strength and elasticity, and decrease in sebaceous gland secretions are common in aging individuals, leading to a higher demand for dermatology drugs.

Dermatology is a diverse specialty encompassing disorders and diseases of the skin, mucous membrane, hair, and nails. Conditions in this category include acne, multiple inflammatory dermatoses, skin cancers, autoimmune disease, occupational dermatitis, and contact dermatitis. It's a highly fragmented therapeutic area, under which comes acne, rosacea, psoriasis, atopic dermatitis, and other disorders.

Biologics are becoming a popular treatment option for dermatological conditions due to their effectiveness and targeted approach, with many drugs approved by regulatory bodies and more in development. Patients also increasingly prefer topical treatments over systemic medications due to convenience, fewer side effects, and targeted approach, leading to a rise in the demand for topical dermatology drugs. The rising demand in emerging markets, increasing adoption of combination therapies, and focus on personalized medicine are also driving growth in the industry.

For instance, In March 2022, Johnson & Johnson's Janssen Pharmaceutical Companies initiated a prospective clinical trial named VISIBLE to evaluate the safety and efficacy of a drug for people of color suffering from moderate to severe plaque and/or scalp psoriasis.

Dermatology Drugs Market Report Highlights

  • Psoriasis segment is accounted for the largest market share because of the increasing the prevalence of psoriasis globally and manufacturers launching new medications for the treatment.
  • Corticosteroids segment holds the highest CAGR of the market. in various conditions of skin disorders topical corticosteroids are used widely in conditions such as psoriasis, dermatitis, acne and others.
  • parenteral segment holds the largest share in the market, due to various biologics are available for the dermatological conditions, and biologics are generally taken through the parenteral route of administration.
  • Hospital pharmacy segment dominated the market and willing to continue its dominance over the forecast period. Nowadays peoples are aware with the skin diseases that's why increased in the patient visits to hospitals and sales of prescription drugs increased.
  • North America holds the largest market share in the market and expected to maintain its dominance during the forecast period. Increased in the awareness of skin diseases and raising the treatment and key players making the developments in this market fuels the growth of the region.
  • The global key market players include: Lupin, Novartis AG, F. Hoffmann-La Roche Ltd, Pfizer Inc., Sanofi, Amgen Inc., Lilly, AstraZeneca, AbbVie Inc., Johnson & Johnson Private Limited, LEO Pharma A/S, Merck & Co. Inc., Bausch Health Companies Inc., and Bristol-Myers Squibb Company.

Polaris Market Research has segmented the dermatology drugs market report based on therapeutic area, drug class, route of administration, distribution channel, and region:

Dermatology Drugs, Therapeutic Area Outlook (Revenue - USD Billion, 2019 - 2032)

  • Acne
  • Atopic Dermatitis
  • Psoriasis
  • Rosacea
  • Others

Dermatology Drugs, Drug Class Outlook (Revenue - USD Billion, 2019 - 2032)

  • Anti-infectives
  • Corticosteroids
  • Anti-acne
  • Calcineurin Inhibitors
  • Retinoids
  • Others

Dermatology Drugs, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

  • Topical
  • Oral
  • Parenteral

Dermatology Drugs, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Dermatology Drugs, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Dermatology Drugs Market Insights

  • 4.1. Dermatology Drugs - Industry Snapshot
  • 4.2. Dermatology Drugs Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Elderly Population
      • 4.2.1.2. Rise in Clinical Studies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Dermatology Drugs Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Dermatology Drugs Market, by Therapeutic Area

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • 5.3. Acne
    • 5.3.1. Global Dermatology Drugs Market, by Acne, by Region, 2019-2032 (USD Billion)
  • 5.4. Atopic Dermatitis
    • 5.4.1. Global Dermatology Drugs Market, by Atopic Dermatitis, by Region, 2019-2032 (USD Billion)
  • 5.5. Psoriasis
    • 5.5.1. Global Dermatology Drugs Market, by Psoriasis, by Region, 2019-2032 (USD Billion)
  • 5.6. Rosacea
    • 5.6.1. Global Dermatology Drugs Market, by Rosacea, by Region, 2019-2032 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Dermatology Drugs Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Dermatology Drugs Market, by Drug Class

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • 6.3. Anti-infectives
    • 6.3.1. Global Dermatology Drugs Market, by Anti-infectives, by Region, 2019-2032 (USD Billion)
  • 6.4. Corticosteroids
    • 6.4.1. Global Dermatology Drugs Market, by Corticosteroids, by Region, 2019-2032 (USD Billion)
  • 6.5. Anti-acne
    • 6.5.1. Global Dermatology Drugs Market, by Anti-acne, by Region, 2019-2032 (USD Billion)
  • 6.6. Calcineurin Inhibitors
    • 6.6.1. Global Dermatology Drugs Market, by Calcineurin Inhibitors, by Region, 2019-2032 (USD Billion)
  • 6.7. Retinoids
    • 6.7.1. Global Dermatology Drugs Market, by Retinoids, by Region, 2019-2032 (USD Billion)
  • 6.8. Others
    • 6.8.1. Global Dermatology Drugs Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Dermatology Drugs Market, by Route of Administration

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 7.3. Topical
    • 7.3.1. Global Dermatology Drugs Market, by Topical, by Region, 2019-2032 (USD Billion)
  • 7.4. Oral
    • 7.4.1. Global Dermatology Drugs Market, by Oral, by Region, 2019-2032 (USD Billion)
  • 7.5. Parenteral
    • 7.5.1. Global Dermatology Drugs Market, by Parenteral, by Region, 2019-2032 (USD Billion)

8. Global Dermatology Drugs Market, by Distribution Channel

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.3. Hospital Pharmacy
    • 8.3.1. Global Dermatology Drugs Market, by Hospital Pharmacy, by Region, 2019-2032 (USD Billion)
  • 8.4. Retail Pharmacy
    • 8.4.1. Global Dermatology Drugs Market, by Retail Pharmacy, by Region, 2019-2032 (USD Billion)
  • 8.5. Online Pharmacy
    • 8.5.1. Global Dermatology Drugs Market, by Online Pharmacy, by Region, 2019-2032 (USD Billion)

9. Global Dermatology Drugs Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Dermatology Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 9.3. Dermatology Drugs Market - North America
    • 9.3.1. North America: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.3.2. North America: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.3.3. North America: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
    • 9.3.4. North America: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.3.5. Dermatology Drugs Market - U.S.
      • 9.3.5.1. U.S.: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.3.5.2. U.S.: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.3.5.3. U.S.: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.3.5.4. U.S.: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.3.6. Dermatology Drugs Market - Canada
      • 9.3.6.1. Canada: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.3.6.2. Canada: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.3.6.3. Canada: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.3.6.4. Canada: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 9.4. Dermatology Drugs Market - Europe
    • 9.4.1. Europe: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.4.2. Europe: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.4.3. Europe: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
    • 9.4.4. Europe: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.4.5. Dermatology Drugs Market - UK
      • 9.4.5.1. UK: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.4.5.2. UK: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.5.3. UK: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.4.5.4. UK: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.4.6. Dermatology Drugs Market - France
      • 9.4.6.1. France: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.4.6.2. France: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.6.3. France: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.4.6.4. France: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.4.7. Dermatology Drugs Market - Germany
      • 9.4.7.1. Germany: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.4.7.2. Germany: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.7.3. Germany: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.4.7.4. Germany: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.4.8. Dermatology Drugs Market - Italy
      • 9.4.8.1. Italy: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.4.8.2. Italy: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.8.3. Italy: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.4.8.4. Italy: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.4.9. Dermatology Drugs Market - Spain
      • 9.4.9.1. Spain: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.4.9.2. Spain: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.9.3. Spain: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.4.9.4. Spain: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.4.10. Dermatology Drugs Market - Netherlands
      • 9.4.10.1. Netherlands: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.4.10.2. Netherlands: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.10.3. Netherlands: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.4.10.4. Netherlands: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.4.11. Dermatology Drugs Market - Russia
      • 9.4.11.1. Russia: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.4.11.2. Russia.: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.4.11.3. Russia: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.4.11.4. Russia: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 9.5. Dermatology Drugs Market - Asia Pacific
    • 9.5.1. Asia Pacific: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.5.2. Asia Pacific: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.5.3. Asia Pacific: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
    • 9.5.4. Asia Pacific: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.5.5. Dermatology Drugs Market - China
      • 9.5.5.1. China: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.5.5.2. China.: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.5.3. China: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.5.5.4. China: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.5.6. Dermatology Drugs Market - India
      • 9.5.6.1. India: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.5.6.2. India.: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.6.3. India: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.5.6.4. India: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.5.7. Dermatology Drugs Market - Japan
      • 9.5.7.1. Japan: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.5.7.2. Japan.: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.7.3. Japan: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.5.7.4. Japan: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.5.8. Dermatology Drugs Market - Malaysia
      • 9.5.8.1. Malaysia: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.5.8.2. Malaysia.: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.8.3. Malaysia: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.5.8.4. Malaysia: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.5.9. Dermatology Drugs Market - Indonesia
      • 9.5.9.1. Indonesia: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.5.9.2. Indonesia.: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.9.3. Indonesia: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.5.9.4. Indonesia: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.5.10. Dermatology Drugs Market - South Korea
      • 9.5.10.1. South Korea: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.5.10.2. South Korea.: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.5.10.3. South Korea: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.5.10.4. South Korea: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 9.6. Dermatology Drugs Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.6.2. Middle East & Africa: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.6.3. Middle East & Africa: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
    • 9.6.4. Middle East & Africa: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.6.5. Dermatology Drugs Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.6.6. Dermatology Drugs Market - South Africa
      • 9.6.6.1. South Africa: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.6.6.2. South Africa: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.6.6.3. South Africa: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.6.6.4. South Africa: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.6.7. Dermatology Drugs Market - Israel
      • 9.6.7.1. Israel: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.6.7.2. Israel: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.6.7.3. Israel: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.6.7.4. Israel: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.6.8. Dermatology Drugs Market - UAE
      • 9.6.8.1. UAE: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.6.8.2. UAE: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.6.8.3. UAE: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.6.8.4. UAE: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • 9.7. Dermatology Drugs Market - Latin America
    • 9.7.1. Latin America: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.7.2. Latin America: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 9.7.3. Latin America: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
    • 9.7.4. Latin America: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.7.5. Dermatology Drugs Market - Mexico
      • 9.7.5.1. Mexico: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.7.5.2. Mexico: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.7.5.3. Mexico: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.7.5.4. Mexico: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.7.6. Dermatology Drugs Market - Brazil
      • 9.7.6.1. Brazil: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.7.6.2. Brazil: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.7.6.3. Brazil: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.7.6.4. Brazil: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
    • 9.7.7. Dermatology Drugs Market - Argentina
      • 9.7.7.1. Argentina: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
      • 9.7.7.2. Argentina: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 9.7.7.3. Argentina: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
      • 9.7.7.4. Argentina: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Lupin
    • 11.1.1. Company Overview
    • 11.1.2. Financial PerRoute of Administrationance
    • 11.1.3. Distribution Channel Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Novartis AG
    • 11.2.1. Company Overview
    • 11.2.2. Financial PerRoute of Administrationance
    • 11.2.3. Distribution Channel Benchmarking
    • 11.2.4. Recent Development
  • 11.3. F. Hoffmann-La Roche Ltd
    • 11.3.1. Company Overview
    • 11.3.2. Financial PerRoute of Administrationance
    • 11.3.3. Distribution Channel Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Pfizer Inc
    • 11.4.1. Company Overview
    • 11.4.2. Financial PerRoute of Administrationance
    • 11.4.3. Distribution Channel Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Sanofi
    • 11.5.1. Company Overview
    • 11.5.2. Financial PerRoute of Administrationance
    • 11.5.3. Distribution Channel Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Amgen Inc
    • 11.6.1. Company Overview
    • 11.6.2. Financial PerRoute of Administrationance
    • 11.6.3. Distribution Channel Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Lilly
    • 11.7.1. Company Overview
    • 11.7.2. Financial PerRoute of Administrationance
    • 11.7.3. Distribution Channel Benchmarking
    • 11.7.4. Recent Development
  • 11.8. AstraZeneca
    • 11.8.1. Company Overview
    • 11.8.2. Financial PerRoute of Administrationance
    • 11.8.3. Distribution Channel Benchmarking
    • 11.8.4. Recent Development
  • 11.9. AbbVie Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Financial PerRoute of Administrationance
    • 11.9.3. Distribution Channel Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Johnson & Johnson Private Limited
    • 11.10.1. Company Overview
    • 11.10.2. Financial PerRoute of Administrationance
    • 11.10.3. Distribution Channel Benchmarking
    • 11.10.4. Recent Development
  • 11.11. LEO Pharma A/S
    • 11.11.1. Company Overview
    • 11.11.2. Financial PerRoute of Administrationance
    • 11.11.3. Distribution Channel Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Merck & Co. Inc
    • 11.12.1. Company Overview
    • 11.12.2. Financial PerRoute of Administrationance
    • 11.12.3. Distribution Channel Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Bausch Health Companies Inc
    • 11.13.1. Company Overview
    • 11.13.2. Financial PerRoute of Administrationance
    • 11.13.3. Distribution Channel Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Bristol-Myers Squibb Company
    • 11.14.1. Company Overview
    • 11.14.2. Financial PerRoute of Administrationance
    • 11.14.3. Distribution Channel Benchmarking
    • 11.14.4. Recent Development

List of Tables

  • Table 1 Global Dermatology Drugs Market, by Therapeutic Area, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Dermatology Drugs Market, by Drug Class, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Dermatology Drugs Market, by Route of Administration, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Dermatology Drugs Market, by Distribution Channel, by Region, 2019-2032 (USD Billion)
  • Table 5 Dermatology Drugs Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 6 North America: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 7 North America: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 8 North America: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 9 North America: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 10 U.S.: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 11 U.S.: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 12 U.S.: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 13 U.S.: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 14 Canada: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 15 Canada: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 16 Canada: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 17 Canada: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 18 Europe: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 19 Europe: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 20 Europe: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 21 Europe: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 22 Germany: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 23 Germany: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 24 Germany: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 25 Germany: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 26 France: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 27 France: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 28 France: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 29 France: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 30 UK: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 31 UK: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 32 UK: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 33 UK: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 34 Italy: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 35 Italy: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 36 Italy: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 37 Italy: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 38 Netherlands: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 39 Netherlands: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 40 Netherlands: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 41 Netherlands: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 42 Spain: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 43 Spain: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 44 Spain: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 45 Spain: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 46 Russia: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 47 Russia: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 48 Russia: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 49 Russia: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 50 Asia Pacific: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 51 Asia Pacific: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 52 Asia Pacific: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 53 Asia Pacific: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 54 China: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 55 China: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 56 China: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 57 China: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 58 Japan: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 59 Japan: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 60 Japan: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 61 Japan: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 62 India: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 63 India: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 64 India: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 65 India: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 66 Indonesia: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 67 Indonesia: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 68 Indonesia: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 69 Indonesia: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 70 Malaysia: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 71 Malaysia: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 72 Malaysia: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 73 Malaysia: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 74 South Korea: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 75 South Korea: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 76 South Korea: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 77 South Korea: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 78 Latin America: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 79 Latin America: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 80 Latin America: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 81 Latin America: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 82 Brazil: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 83 Brazil: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 84 Brazil: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 85 Brazil: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 86 Mexico: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 87 Mexico: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 88 Mexico: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 89 Mexico: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 90 Argentina: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 91 Argentina: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 92 Argentina: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 93 Argentina: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 94 Middle East & Africa: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 95 Middle East & Africa: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 96 Middle East & Africa: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 97 Middle East & Africa: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 98 UAE: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 99 UAE: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 100 UAE: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 101 UAE: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 102 Saudi Arabia: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 103 Saudi Arabia: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 104 Saudi Arabia: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 105 Saudi Arabia: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 106 South Africa: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 107 South Africa: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 108 South Africa: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 109 South Africa: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 110 Israel: Dermatology Drugs Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • Table 111 Israel: Dermatology Drugs Market, by Drug Class, 2019-2032 (USD Billion)
  • Table 112 Israel: Dermatology Drugs Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 113 Israel: Dermatology Drugs Market, by Distribution Channel, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Dermatology Drugs Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Distribution Channel
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Therapeutic Area
  • Figure 7. Global Dermatology Drugs Market, by Therapeutic Area, 2021 & 2030 (USD Billion)
  • Figure 8. Market by Distribution Channel
  • Figure 9. Global Dermatology Drugs Market, by Distribution Channel, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Drug Class
  • Figure 11. Global Dermatology Drugs Market, by Drug Class, 2021 & 2030 (USD Billion)
  • Figure 12. Market by Route of Administration
  • Figure 13. Global Dermatology Drugs Market, by Route of Administration, 2021 & 2030 (USD Billion)